Cooper Companies | COO - Pasivo Circulante





Pasivo Circulante Cambio Fecha
Abbott USD 18.38B 1.88B 2026-03
Align Technology USD 1.91B 14.16M 2026-03
AtriCure USD 73.19M 8.33M 2026-03
Avanos Medical USD 131.2M 34M 2026-03
Bausch Health Companies USD 4.53B 350M 2026-03
Baxter International USD 3.69B 723M 2026-03
Bayer EUR 33.46B 875M 2026-03
Becton, Dickinson and Co. USD 8.51B 254M 2026-03
Boston Scientific USD 4.57B 868M 2026-03
Cooper Companies USD 1.6B 482.9M 2025-12
Dentsply International USD 1.21B 136M 2026-03
Dexcom USD 2.22B 81.3M 2026-03
Edwards Lifesciences USD 1.41B 404.7M 2026-03
Globus Medical USD 482.46M 16.04M 2026-03
Haemonetics USD 282.6M 257.27M 2026-03
Inogen USD 64.94M 2.12M 2025-09
Insulet USD 687.5M 7.4M 2026-03
Integra LifeSciences USD 346.85M 109.14M 2026-03
Intuitive Surgical USD 2.51B 3.2M 2026-03
J&J USD 57.72B 3.59B 2026-03
Medtronic USD 9.5B 440M 2025-12
Merit Medical Systems USD 216.87M 22.89M 2026-03
Novartis USD 27.28B 4.72B 2025-12
ResMed USD 1.35B 103.1M 2026-03
STAAR Surgical USD 60.99M 7.51M 2026-03
Steris USD 1.14B 222.7M 2026-03
Stryker USD 6.32B 1.48B 2026-03
Tandem Diabetes Care USD 247.96M 5.24M 2026-03
Teleflex USD 728.05M 33.98M 2026-03
Utah Medical Products USD 2.6M 413K 2025-12
Zimmer Biomet Holdings USD 2.86B 280.6M 2026-03